Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) – Drugs In Development, 2021

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus (HIV) Infections (AIDS) – Drugs In Development, 2021, provides an overview of the Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) pipeline landscape.HIV is a virus which attacks the immune system, and weakens ability to fight infections and disease. Symptoms include fever, sore throat, body rash, joint pain, muscle pain and swollen glands. The most common ways HIV is spread are by having vaginal or anal intercourse without a condom with someone who has HIV/AIDS, sharing needles or syringes with someone who has HIV/AIDS, being deeply punctured with a needle or surgical instrument contaminated with HIV and getting HIV-infected blood, semen, or vaginal secretions into open wounds or sores.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Human Immunodeficiency Virus (HIV) Infections (AIDS) – Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Human Immunodeficiency Virus (HIV) Infections (AIDS) and features dormant and discontinued projects.

The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 9, 2, 14, 45, 56, 1, 2, 113, 79 and 5 respectively. Similarly, the Universities portfolio in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 3, 16, 34, 54 and 68 molecules, respectively.Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease).- The pipeline guide reviews pipeline therapeutics for Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. – The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.- The pipeline guide reviews key companies involved in Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) therapeutics and enlists all their major and minor projects.- The pipeline guide evaluates Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. – The pipeline guide reviews latest news related to pipeline therapeutics for Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.- Find and recognize significant and varied types of therapeutics under development for Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease).- Classify potential new clients or partners in the target demographic.- Develop tactical initiatives by understanding the focus areas of leading companies.- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.- Formulate corrective measures for pipeline projects by understanding Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) pipeline depth and focus of Indication therapeutics.- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies mentioned

2A Pharma AB

AbbVie Inc

Abivax SA

Actinobac Biomed Inc

Adare Pharma Solutions

Advanced Gene and Cell Technologies

Advanced Genetic Systems Inc

Aelix Therapeutics SL

AIM ImmunoTech Inc

Akshaya Bio Inc

AlbaJuna Therapeutics

Alphamab Oncology

AlphaVax Inc

American Gene Technologies International Inc

ANRS Research Center

Antion Biosciences SA

Aphios Corp

Apimeds Inc

Ascletis Pharma Inc

AUM LifeTech Inc

Auro Vaccines LLC

Autonomous Therapeutics Inc

Avixgen Inc

B Cell Design SAS

Biological Mimetics Inc

Bionor Holding AS

Table of Contents

Table of Contents

Introduction

Human Immunodeficiency Virus Infections - Overview

Human Immunodeficiency Virus Infections - Therapeutics Development

Human Immunodeficiency Virus Infections - Therapeutics Assessment

Human Immunodeficiency Virus Infections - Companies Involved in Therapeutics Development

Human Immunodeficiency Virus Infections - Drug Profiles

Human Immunodeficiency Virus Infections - Dormant Projects

Human Immunodeficiency Virus Infections - Discontinued Products

Human Immunodeficiency Virus Infections - Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Human Immunodeficiency Virus (HIV) Infections (AIDS), 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Products under Development by Companies, 2021

Products under Development by Universities/Institutes, 2021

Number of Products by Stage and Target, 2021

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by 2A Pharma AB, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by AbbVie Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Abivax SA, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Actinobac Biomed Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Adare Pharma Solutions, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Advanced Gene and Cell Technologies, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Advanced Genetic Systems Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Aelix Therapeutics SL, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by AIM ImmunoTech Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Akshaya Bio Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by AlbaJuna Therapeutics, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Alphamab Oncology, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by AlphaVax Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by American Gene Technologies International Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ANRS Research Center, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Antion Biosciences SA, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Aphios Corp, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Apimeds Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Ascletis Pharma Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by AUM LifeTech Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Auro Vaccines LLC, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Autonomous Therapeutics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Avixgen Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by B Cell Design SAS, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Biological Mimetics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Bionor Holding AS, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by BioNTech SE, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Biosantech SA, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Biotron Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Blue Therapeutics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Bolder Biotechnology Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Brandenburg Antiinfektiva GmbH, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Brii Biosciences, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Bristol-Myers Squibb Co, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Evotec SE, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Excision BioTherapeutics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ExQor Technologies Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Fox Chase Chemical Diversity Center Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Frontier Biotechnologies Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by FUJIFILM Toyama Chemical Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by GB Sciences Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by GeneCure Biotechnologies LLC, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Genetic Immunity Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by GeoVax Labs Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Gilead Sciences Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Globeimmune Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Greffex Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Gritstone Bio Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by GT Biopharma Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Guangzhou Bio-gene Technology Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by HDT Bio Corp, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Helocyte Biosciences Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Henan Zhenshi Biotechnology Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Hepion Pharmaceuticals Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Hetero Drugs Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Hoverink Biotechnologies Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by iCo Therapeutics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ID Pharma Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by IGXBio Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Immune Modulation Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Immune Response BioPharma Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ImmunityBio Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Immunocore Holdings Plc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Immunologik GmbH, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Innovare R & D SA De CV, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Inovio Pharmaceuticals Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Intarcia Therapeutics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Intrucept Biomedicine LLC, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by InvVax Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ISR Immune System Regulation Holding AB, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Jericho Sciences LLC, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Jiangsu Aidea Pharmaceutical Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Johnson & Johnson, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Kainos Medicine Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Kanglin Biotech Hangzhou Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Karyopharm Therapeutics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Kymab Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Lauren Sciences LLC, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Legend Biotech Corp, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Longevity Biotech Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Looove Biotechnology Beijing Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Luckwel Pharmaceuticals Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Lyndra Therapeutics Inc., 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by MacroGenics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Mapp Biopharmaceutical Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Merck & Co Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by METiS Pharmaceuticals, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Miltenyi Biotec BV & Co KG, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Minka Therapeutics SA, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Moderna Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Molecular Express Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Moleculin Biotech Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Mologen AG, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Mutabilis SA, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Mycenax Biotech Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Mymetics Corp, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by NanoViricides Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Navigen Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by NeED Pharma srl, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Neuraxpharm France SAS, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by New World Laboratories Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by NovalGen Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Novartis AG, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Novodux, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Omeros Corp, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Oncotelic Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Oncovir Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by OncXerna Therapeutics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Orion Biotechnology Canada Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Osel Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by OyaGen Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Palisades Therapeutics, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Pepscan Therapeutics BV, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Pharmsynthez, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Phoenix Biotechnology Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by PlantForm Corp, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Prosetta Biosciences Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Protheragen Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by PROVIREX Genome Editing Therapies GmbH, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Qura Therapeutics LLC, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Recombio SL, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Repair Biotechnologies Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Replikins Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Resverlogix Corp, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by RetroVirox Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Rodos BioTarget GmbH, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Samjin Pharm Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sangamo Therapeutics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Savoy Pharmaceuticals Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Secura Bio Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Serum Institute of India Pvt Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Shanghai De Novo Pharmatech Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Shanghai Pharmaceutical Group Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Shanxi Kangbao Biological Product Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Shionogi & Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by SignalRx Pharmaceuticals Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sirga Advanced Biopharma Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by SMET Pharmaceutical Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ST Pharm Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Staidson BioPharma Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Starpharma Holdings Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sumagen Co Ltd, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sunomix Therapeutics, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Susavion Biosciences Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Taiga Biotechnologies Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by TaiMed Biologics Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Takara Bio Inc, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects, 2021

Human Immunodeficiency Virus (HIV) Infections (AIDS) – Discontinued Products, 2021

List of Figures

List of Figures

Number of Products under Development for Human Immunodeficiency Virus (HIV) Infections (AIDS), 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Number of Products by Top 10 Targets, 2021

Number of Products by Stage and Top 10 Targets, 2021

Number of Products by Top 10 Mechanism of Actions, 2021

Number of Products by Stage and Top 10 Mechanism of Actions, 2021

Number of Products by Top 10 Routes of Administration, 2021

Number of Products by Stage and Top 10 Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports